| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 10.645 | 28.661 | 15.212 | 16.774 | 20.258 | 20.892 |
| Total Income - EUR | - | - | - | - | 10.645 | 32.208 | 17.519 | 20.671 | 20.967 | 24.447 |
| Total Expenses - EUR | - | - | - | - | 11.830 | 30.259 | 19.106 | 19.798 | 19.669 | 20.872 |
| Gross Profit/Loss - EUR | - | - | - | - | -1.185 | 1.949 | -1.586 | 873 | 1.298 | 3.576 |
| Net Profit/Loss - EUR | - | - | - | - | -1.185 | 1.840 | -1.739 | 705 | 1.100 | 2.961 |
| Employees | - | - | - | - | 1 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Sanoactiv Rb S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 2.059 | 5.153 | 3.971 | 2.900 | 2.182 | 1.644 |
| Current Assets | - | - | - | - | 22.907 | 2.369 | 1.773 | 1.393 | 1.720 | 4.916 |
| Inventories | - | - | - | - | 310 | 0 | 0 | 0 | 58 | 0 |
| Receivables | - | - | - | - | 10.417 | 741 | 669 | 0 | 0 | 905 |
| Cash | - | - | - | - | 12.180 | 1.628 | 1.105 | 1.393 | 1.662 | 4.012 |
| Shareholders Funds | - | - | - | - | -1.143 | 718 | -1.036 | -335 | 766 | 3.723 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 3.037 | 1.703 | 2.841 | 1.728 | 954 | 1.193 |
| Income in Advance | - | - | - | - | 23.072 | 5.102 | 3.940 | 2.900 | 2.182 | 1.644 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8695 - 8695" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Sanoactiv Rb S.r.l.